Page last updated: 2024-10-21

3,4-methylenedioxyamphetamine and Anemia, Hemolytic

3,4-methylenedioxyamphetamine has been researched along with Anemia, Hemolytic in 1 studies

3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.

Anemia, Hemolytic: A condition of inadequate circulating red blood cells (ANEMIA) or insufficient HEMOGLOBIN due to premature destruction of red blood cells (ERYTHROCYTES).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Woodrow, G1
Harnden, P1
Turney, JH1

Other Studies

1 other study available for 3,4-methylenedioxyamphetamine and Anemia, Hemolytic

ArticleYear
Acute renal failure due to accelerated hypertension following ingestion of 3,4-methylenedioxymethamphetamine ('ecstasy').
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1995, Volume: 10, Issue:3

    Topics: 3,4-Methylenedioxyamphetamine; Acute Kidney Injury; Adult; Anemia, Hemolytic; Blood Pressure; Brain

1995